A revolutionary pancreatic cancer drug in late-stage clinical trials is extending the life of former Sen. Ben Sasse, but it is also causing painful skin side effects.

Sasse, who retired from politics in 2023 to become the president of the University of Florida, was diagnosed in December 2025 with advanced pancreatic cancer, the third most deadly form of cancer in the United States according to the National Cancer Institute.